
Turenne Capital
Description
Turenne Capital is a leading French private equity and venture capital firm, headquartered in Paris, with a significant footprint in the domestic investment landscape. As a key player in capital investment, the firm manages an impressive portfolio exceeding €1.5 billion in assets under management. Turenne Capital is dedicated to fostering the growth and development of French small and medium-sized enterprises (SMEs) and mid-cap companies, providing crucial financial and strategic support across various stages of their lifecycle.
The firm employs a multi-faceted investment strategy, encompassing Capital Innovation, Capital Développement, Capital Transmission, and Capital Santé. Their Capital Innovation arm specifically targets early-stage and innovative companies, providing venture capital funding to promising startups. For these ventures, Turenne Capital typically deploys initial cheques ranging from €0.5 million to €5 million, aiming to fuel their initial growth and market penetration. Beyond early-stage investments, their Capital Développement and Capital Transmission strategies focus on growth equity and buyout opportunities, respectively, for more mature businesses.
With over two decades of experience, Turenne Capital boasts a robust track record, having supported more than 250 companies since its inception. This extensive portfolio reflects their commitment to driving economic expansion and innovation across diverse sectors within France. The firm prides itself on establishing long-term partnerships with its portfolio companies, offering not just capital but also strategic guidance and operational expertise to help them achieve their full potential and contribute to the broader French economy.
Investor Profile
Turenne Capital has backed more than 53 startups, with 3 new investments in the last 12 months alone. The firm has led 14 rounds, about 26% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series A, Private Equity rounds (top funding stages).
- Majority of deals are located in France, Germany, United States.
- Strong thematic focus on Software, Biotechnology, Health Care.
- Led 1 rounds in the past year.
- Typical check size: $540K – $5.4M.
Stage Focus
- Series Unknown (38%)
- Series A (25%)
- Private Equity (15%)
- Series B (13%)
- Seed (6%)
- Series C (4%)
Country Focus
- France (91%)
- Germany (6%)
- United States (2%)
- Poland (2%)
Industry Focus
- Software
- Biotechnology
- Health Care
- Medical
- Internet
- Information Technology
- E-commerce
- Manufacturing
- Medical Device
- Pharmaceutical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.